Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Idiopathic Pulmonary Fibrosis | 45 | 2020 | 337 | 15.570 |
Why?
|
Mucin-5B | 34 | 2019 | 152 | 12.630 |
Why?
|
Lipopolysaccharides | 59 | 2013 | 902 | 8.220 |
Why?
|
Pulmonary Fibrosis | 46 | 2019 | 339 | 8.000 |
Why?
|
Genetic Predisposition to Disease | 59 | 2020 | 2214 | 5.630 |
Why?
|
Lung | 78 | 2019 | 3344 | 5.350 |
Why?
|
Immunity, Innate | 30 | 2019 | 672 | 4.550 |
Why?
|
Asthma | 38 | 2019 | 1777 | 4.410 |
Why?
|
Polymorphism, Genetic | 30 | 2018 | 804 | 3.980 |
Why?
|
Environmental Exposure | 18 | 2019 | 393 | 3.920 |
Why?
|
Toll-Like Receptor 4 | 38 | 2014 | 355 | 3.890 |
Why?
|
Lung Diseases, Interstitial | 22 | 2019 | 358 | 3.810 |
Why?
|
Membrane Glycoproteins | 21 | 2010 | 520 | 3.780 |
Why?
|
Receptors, Cell Surface | 20 | 2015 | 410 | 3.660 |
Why?
|
Lung Diseases | 19 | 2018 | 709 | 3.560 |
Why?
|
Dust | 22 | 2018 | 67 | 3.480 |
Why?
|
Epigenesis, Genetic | 16 | 2018 | 394 | 3.410 |
Why?
|
DNA Methylation | 15 | 2018 | 347 | 3.350 |
Why?
|
Genome-Wide Association Study | 25 | 2020 | 945 | 3.200 |
Why?
|
Respiratory Mucosa | 17 | 2019 | 261 | 2.890 |
Why?
|
Endotoxins | 20 | 2013 | 251 | 2.850 |
Why?
|
Promoter Regions, Genetic | 22 | 2019 | 1265 | 2.770 |
Why?
|
Genetic Variation | 16 | 2019 | 918 | 2.670 |
Why?
|
Pneumonia | 17 | 2012 | 464 | 2.630 |
Why?
|
Bronchoalveolar Lavage Fluid | 47 | 2015 | 643 | 2.590 |
Why?
|
Drosophila Proteins | 13 | 2002 | 187 | 2.570 |
Why?
|
Respiratory Tract Diseases | 12 | 2010 | 147 | 2.440 |
Why?
|
Bronchial Hyperreactivity | 18 | 2015 | 117 | 2.370 |
Why?
|
Toll-Like Receptors | 24 | 2018 | 186 | 2.340 |
Why?
|
Mice | 102 | 2019 | 14492 | 2.320 |
Why?
|
Polymorphism, Single Nucleotide | 27 | 2019 | 1902 | 2.250 |
Why?
|
Zea mays | 12 | 2001 | 47 | 2.060 |
Why?
|
Animals | 132 | 2019 | 33753 | 1.990 |
Why?
|
Gene Expression | 21 | 2020 | 1503 | 1.960 |
Why?
|
Humans | 230 | 2020 | 99095 | 1.930 |
Why?
|
Quantitative Trait Loci | 8 | 2018 | 296 | 1.740 |
Why?
|
Genomics | 11 | 2018 | 432 | 1.740 |
Why?
|
Genotype | 22 | 2018 | 2027 | 1.740 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 12 | 2019 | 925 | 1.730 |
Why?
|
Bleomycin | 8 | 2019 | 206 | 1.720 |
Why?
|
Cytokines | 30 | 2019 | 1836 | 1.720 |
Why?
|
Male | 169 | 2020 | 56464 | 1.700 |
Why?
|
Mice, Inbred C57BL | 49 | 2018 | 4943 | 1.620 |
Why?
|
Pulmonary Surfactant-Associated Protein C | 4 | 2019 | 37 | 1.620 |
Why?
|
Genetic Loci | 8 | 2019 | 275 | 1.550 |
Why?
|
Mucociliary Clearance | 2 | 2018 | 33 | 1.550 |
Why?
|
Respiratory Hypersensitivity | 6 | 2018 | 91 | 1.550 |
Why?
|
Administration, Inhalation | 26 | 2013 | 626 | 1.460 |
Why?
|
Middle Aged | 101 | 2020 | 26736 | 1.430 |
Why?
|
Female | 132 | 2020 | 57260 | 1.360 |
Why?
|
Gene Expression Profiling | 21 | 2019 | 1503 | 1.320 |
Why?
|
Crohn Disease | 4 | 2020 | 110 | 1.300 |
Why?
|
Mucus | 4 | 2019 | 47 | 1.290 |
Why?
|
Oligonucleotide Array Sequence Analysis | 18 | 2016 | 864 | 1.290 |
Why?
|
Neutrophils | 24 | 2012 | 1121 | 1.250 |
Why?
|
Macrophages | 15 | 2016 | 1099 | 1.240 |
Why?
|
Hypersensitivity | 6 | 2014 | 243 | 1.230 |
Why?
|
Signal Transduction | 24 | 2020 | 4773 | 1.210 |
Why?
|
Lung Transplantation | 6 | 2017 | 365 | 1.200 |
Why?
|
Case-Control Studies | 25 | 2020 | 3107 | 1.190 |
Why?
|
RNA | 7 | 2019 | 744 | 1.180 |
Why?
|
Tumor Necrosis Factor-alpha | 23 | 2017 | 1207 | 1.170 |
Why?
|
Disease Models, Animal | 27 | 2019 | 3673 | 1.160 |
Why?
|
Occupational Exposure | 10 | 2018 | 277 | 1.160 |
Why?
|
Graft Rejection | 5 | 2007 | 630 | 1.130 |
Why?
|
Inhalation Exposure | 5 | 2012 | 94 | 1.120 |
Why?
|
Phenotype | 24 | 2019 | 2723 | 1.110 |
Why?
|
Occupational Diseases | 10 | 2008 | 138 | 1.090 |
Why?
|
Edible Grain | 8 | 2003 | 42 | 1.090 |
Why?
|
Pulmonary Alveoli | 6 | 2016 | 377 | 1.080 |
Why?
|
Aged | 57 | 2020 | 18247 | 1.060 |
Why?
|
Mice, Inbred Strains | 15 | 2016 | 459 | 1.040 |
Why?
|
Asbestos | 8 | 2012 | 18 | 1.030 |
Why?
|
Gene Expression Regulation | 20 | 2019 | 2536 | 1.020 |
Why?
|
Adult | 78 | 2020 | 29071 | 1.020 |
Why?
|
Mutation | 16 | 2019 | 3136 | 1.020 |
Why?
|
Caenorhabditis elegans | 5 | 2013 | 370 | 1.010 |
Why?
|
Smoking | 24 | 2020 | 1520 | 0.980 |
Why?
|
Ventilator-Induced Lung Injury | 2 | 2019 | 45 | 0.980 |
Why?
|
Ozone | 6 | 2012 | 86 | 0.970 |
Why?
|
Sequence Analysis, DNA | 8 | 2019 | 807 | 0.970 |
Why?
|
Mice, Inbred C3H | 16 | 2010 | 264 | 0.970 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 4 | 2019 | 42 | 0.950 |
Why?
|
Receptors, Immunologic | 3 | 2015 | 230 | 0.950 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2018 | 357 | 0.930 |
Why?
|
Mice, Knockout | 21 | 2019 | 2765 | 0.920 |
Why?
|
Nasal Mucosa | 3 | 2017 | 97 | 0.890 |
Why?
|
Pulmonary Surfactant-Associated Proteins | 1 | 2019 | 12 | 0.890 |
Why?
|
Metagenomics | 2 | 2011 | 85 | 0.890 |
Why?
|
Risk Factors | 27 | 2020 | 8301 | 0.880 |
Why?
|
Cysts | 2 | 2019 | 87 | 0.880 |
Why?
|
Orthomyxoviridae Infections | 1 | 2019 | 45 | 0.870 |
Why?
|
Inflammation | 25 | 2017 | 2064 | 0.870 |
Why?
|
Respiratory Function Tests | 16 | 2016 | 535 | 0.870 |
Why?
|
Aspartic Acid | 2 | 2014 | 90 | 0.860 |
Why?
|
Macrophages, Alveolar | 10 | 2009 | 349 | 0.860 |
Why?
|
Alpha-Globulins | 3 | 2009 | 14 | 0.830 |
Why?
|
Maternal Exposure | 3 | 2018 | 113 | 0.820 |
Why?
|
Translational Medical Research | 2 | 2019 | 183 | 0.820 |
Why?
|
Paraquat | 1 | 2018 | 14 | 0.810 |
Why?
|
Glycine | 2 | 2014 | 163 | 0.810 |
Why?
|
Lipopolysaccharide Receptors | 4 | 2007 | 82 | 0.800 |
Why?
|
Disease | 3 | 2011 | 82 | 0.800 |
Why?
|
Airway Obstruction | 5 | 1998 | 134 | 0.790 |
Why?
|
Herbicides | 1 | 2018 | 24 | 0.790 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2018 | 29 | 0.790 |
Why?
|
Cellular Senescence | 1 | 2019 | 146 | 0.790 |
Why?
|
Rectal Fistula | 1 | 2017 | 12 | 0.790 |
Why?
|
Transcriptome | 5 | 2016 | 428 | 0.780 |
Why?
|
Shock, Septic | 4 | 2011 | 144 | 0.780 |
Why?
|
Electronic Nicotine Delivery Systems | 1 | 2018 | 29 | 0.770 |
Why?
|
RNA, Messenger | 18 | 2017 | 2937 | 0.770 |
Why?
|
Vital Capacity | 18 | 2015 | 227 | 0.760 |
Why?
|
Respiratory System | 6 | 2009 | 142 | 0.760 |
Why?
|
Air Pollutants, Occupational | 4 | 2009 | 34 | 0.750 |
Why?
|
Neutrophil Infiltration | 4 | 2012 | 106 | 0.740 |
Why?
|
Complement C3 | 1 | 2018 | 171 | 0.740 |
Why?
|
Escherichia coli | 14 | 2011 | 799 | 0.740 |
Why?
|
Genome, Human | 4 | 2015 | 366 | 0.730 |
Why?
|
Bronchioles | 1 | 2016 | 28 | 0.730 |
Why?
|
Digestive System Surgical Procedures | 1 | 2017 | 87 | 0.720 |
Why?
|
Desmoplakins | 1 | 2016 | 21 | 0.710 |
Why?
|
Alleles | 9 | 2017 | 880 | 0.710 |
Why?
|
Tomography, X-Ray Computed | 18 | 2019 | 2202 | 0.710 |
Why?
|
Patient Outcome Assessment | 1 | 2018 | 119 | 0.710 |
Why?
|
Methamphetamine | 1 | 2017 | 52 | 0.710 |
Why?
|
HLA-DQ beta-Chains | 1 | 2016 | 68 | 0.700 |
Why?
|
Host-Pathogen Interactions | 1 | 2019 | 270 | 0.700 |
Why?
|
Animal Husbandry | 5 | 2018 | 28 | 0.700 |
Why?
|
Interferon-gamma | 7 | 2007 | 775 | 0.700 |
Why?
|
Sequence Analysis, RNA | 3 | 2019 | 290 | 0.690 |
Why?
|
HLA-DRB1 Chains | 1 | 2016 | 101 | 0.680 |
Why?
|
Scleroderma, Systemic | 2 | 2013 | 80 | 0.670 |
Why?
|
Urban Population | 3 | 2015 | 392 | 0.660 |
Why?
|
Idiopathic Interstitial Pneumonias | 4 | 2019 | 41 | 0.650 |
Why?
|
CpG Islands | 4 | 2018 | 85 | 0.650 |
Why?
|
Bronchial Provocation Tests | 8 | 2011 | 49 | 0.640 |
Why?
|
Gram-Negative Bacterial Infections | 3 | 2018 | 45 | 0.610 |
Why?
|
Lung Injury | 3 | 2009 | 198 | 0.610 |
Why?
|
Inhalation | 3 | 2008 | 22 | 0.610 |
Why?
|
Th2 Cells | 4 | 2012 | 170 | 0.600 |
Why?
|
Hyaluronic Acid | 3 | 2009 | 93 | 0.600 |
Why?
|
Leukocytes, Mononuclear | 2 | 2015 | 471 | 0.600 |
Why?
|
Sarcoidosis | 3 | 2013 | 92 | 0.590 |
Why?
|
Health Care Costs | 1 | 2017 | 361 | 0.590 |
Why?
|
Chromosomes, Mammalian | 2 | 2011 | 27 | 0.590 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2013 | 9 | 0.580 |
Why?
|
Immunoglobulin E | 8 | 2015 | 326 | 0.580 |
Why?
|
Epithelial Cells | 4 | 2018 | 1033 | 0.580 |
Why?
|
Intercellular Adhesion Molecule-1 | 3 | 2003 | 185 | 0.580 |
Why?
|
Tobacco Smoke Pollution | 1 | 2015 | 198 | 0.580 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2013 | 34 | 0.570 |
Why?
|
Polymerase Chain Reaction | 11 | 2016 | 1163 | 0.570 |
Why?
|
Allergens | 11 | 2017 | 419 | 0.570 |
Why?
|
Interleukin-10 | 4 | 2006 | 330 | 0.560 |
Why?
|
Cilia | 2 | 2013 | 128 | 0.560 |
Why?
|
GTPase-Activating Proteins | 3 | 2019 | 62 | 0.550 |
Why?
|
Environment | 2 | 2006 | 425 | 0.550 |
Why?
|
Immune Tolerance | 2 | 2013 | 343 | 0.540 |
Why?
|
Forced Expiratory Volume | 17 | 2015 | 455 | 0.540 |
Why?
|
Diffusion of Innovation | 2 | 2018 | 98 | 0.540 |
Why?
|
Respiratory Mechanics | 4 | 1994 | 86 | 0.540 |
Why?
|
PPAR gamma | 1 | 2013 | 173 | 0.530 |
Why?
|
Lipid A | 2 | 2005 | 28 | 0.520 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 543 | 0.520 |
Why?
|
Young Adult | 14 | 2019 | 9561 | 0.510 |
Why?
|
Medicine | 1 | 2012 | 63 | 0.500 |
Why?
|
Air Pollutants | 4 | 2013 | 219 | 0.500 |
Why?
|
Science | 1 | 2012 | 45 | 0.500 |
Why?
|
Health Status | 4 | 2011 | 743 | 0.490 |
Why?
|
RNA Interference | 8 | 2016 | 501 | 0.490 |
Why?
|
Asbestosis | 8 | 1994 | 12 | 0.490 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2011 | 76 | 0.490 |
Why?
|
Agricultural Workers' Diseases | 3 | 1996 | 31 | 0.480 |
Why?
|
Mucin 5AC | 4 | 2015 | 43 | 0.480 |
Why?
|
Pulmonary Emphysema | 2 | 2015 | 245 | 0.470 |
Why?
|
Methacholine Chloride | 10 | 2015 | 54 | 0.470 |
Why?
|
Species Specificity | 8 | 2015 | 634 | 0.470 |
Why?
|
Biomarkers | 9 | 2019 | 2994 | 0.470 |
Why?
|
Hyaluronan Receptors | 3 | 2009 | 88 | 0.460 |
Why?
|
Disease Susceptibility | 3 | 2013 | 268 | 0.460 |
Why?
|
Enterobacteriaceae | 4 | 2013 | 37 | 0.460 |
Why?
|
United States | 19 | 2019 | 10440 | 0.460 |
Why?
|
Lung Diseases, Obstructive | 3 | 2001 | 62 | 0.460 |
Why?
|
Bone Marrow Transplantation | 3 | 2009 | 270 | 0.450 |
Why?
|
Persian Gulf Syndrome | 4 | 2004 | 10 | 0.450 |
Why?
|
DNA | 3 | 2015 | 1388 | 0.440 |
Why?
|
Germ Cells | 1 | 2009 | 48 | 0.440 |
Why?
|
Receptors, Interleukin-1 Type I | 2 | 2007 | 22 | 0.440 |
Why?
|
Biomedical Research | 3 | 2014 | 536 | 0.440 |
Why?
|
Toll-Like Receptor 2 | 6 | 2013 | 155 | 0.440 |
Why?
|
Fetal Growth Retardation | 1 | 2013 | 362 | 0.440 |
Why?
|
Disease Progression | 11 | 2019 | 2257 | 0.430 |
Why?
|
Cohort Studies | 16 | 2018 | 4344 | 0.430 |
Why?
|
Hematopoietic Stem Cells | 3 | 2009 | 310 | 0.430 |
Why?
|
Gain of Function Mutation | 2 | 2018 | 18 | 0.420 |
Why?
|
Karyotyping | 1 | 2008 | 141 | 0.420 |
Why?
|
Mice, Transgenic | 7 | 2019 | 2136 | 0.420 |
Why?
|
Housing, Animal | 1 | 2009 | 44 | 0.420 |
Why?
|
Flour | 1 | 2008 | 6 | 0.420 |
Why?
|
T-Lymphocyte Subsets | 1 | 2012 | 495 | 0.410 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2008 | 22 | 0.410 |
Why?
|
Lung Diseases, Fungal | 1 | 2008 | 14 | 0.410 |
Why?
|
Aspergillosis | 1 | 2008 | 27 | 0.410 |
Why?
|
Plasminogen | 1 | 2008 | 26 | 0.410 |
Why?
|
Graft Survival | 3 | 2007 | 400 | 0.400 |
Why?
|
Complement System Proteins | 2 | 2007 | 190 | 0.400 |
Why?
|
Longevity | 1 | 2009 | 143 | 0.400 |
Why?
|
Caenorhabditis elegans Proteins | 4 | 2013 | 226 | 0.400 |
Why?
|
Prevalence | 12 | 2020 | 2142 | 0.400 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2005 | 101 | 0.400 |
Why?
|
Airway Resistance | 4 | 2011 | 32 | 0.400 |
Why?
|
Otitis Media | 2 | 2019 | 83 | 0.400 |
Why?
|
Transplantation Immunology | 2 | 2005 | 39 | 0.400 |
Why?
|
DNA, Bacterial | 3 | 2014 | 314 | 0.400 |
Why?
|
Pregnancy Complications | 1 | 2013 | 460 | 0.400 |
Why?
|
Chromosome Mapping | 6 | 2011 | 625 | 0.390 |
Why?
|
Immunohistochemistry | 7 | 2015 | 1884 | 0.390 |
Why?
|
Bronchiolitis Obliterans | 2 | 2006 | 87 | 0.390 |
Why?
|
Ovalbumin | 8 | 2015 | 189 | 0.390 |
Why?
|
Mice, Inbred BALB C | 8 | 2015 | 1238 | 0.390 |
Why?
|
Interleukin-1 | 8 | 2003 | 1020 | 0.390 |
Why?
|
Genes | 2 | 2006 | 280 | 0.390 |
Why?
|
Streptococcus | 1 | 2007 | 20 | 0.390 |
Why?
|
Complement Inactivator Proteins | 1 | 2007 | 40 | 0.390 |
Why?
|
Bronchoconstriction | 4 | 2011 | 28 | 0.380 |
Why?
|
Risk Assessment | 11 | 2020 | 2802 | 0.380 |
Why?
|
Cell Line | 10 | 2018 | 2889 | 0.380 |
Why?
|
Leukocyte Count | 7 | 2009 | 289 | 0.380 |
Why?
|
Bronchi | 5 | 2005 | 267 | 0.380 |
Why?
|
Sepsis | 3 | 2010 | 391 | 0.380 |
Why?
|
Aged, 80 and over | 14 | 2019 | 6315 | 0.380 |
Why?
|
European Continental Ancestry Group | 4 | 2017 | 1314 | 0.370 |
Why?
|
Respiratory Distress Syndrome, Adult | 2 | 2018 | 413 | 0.370 |
Why?
|
Hypoxia | 1 | 2013 | 886 | 0.370 |
Why?
|
Total Lung Capacity | 8 | 2015 | 39 | 0.370 |
Why?
|
Telomerase | 2 | 2019 | 217 | 0.370 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2019 | 2233 | 0.370 |
Why?
|
Leukocytes | 3 | 2006 | 255 | 0.360 |
Why?
|
Intracellular Signaling Peptides and Proteins | 5 | 2020 | 424 | 0.360 |
Why?
|
Mutation, Missense | 4 | 2002 | 314 | 0.360 |
Why?
|
Macrophages, Peritoneal | 1 | 2007 | 110 | 0.360 |
Why?
|
DNA Helicases | 2 | 2019 | 108 | 0.350 |
Why?
|
Toxicology | 1 | 2006 | 35 | 0.350 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 282 | 0.350 |
Why?
|
Receptors, CCR5 | 1 | 2006 | 42 | 0.350 |
Why?
|
Physicians | 1 | 2012 | 530 | 0.350 |
Why?
|
Streptococcal Infections | 1 | 2007 | 127 | 0.350 |
Why?
|
Multivariate Analysis | 8 | 2019 | 1596 | 0.350 |
Why?
|
Follow-Up Studies | 13 | 2019 | 4602 | 0.340 |
Why?
|
Logistic Models | 8 | 2019 | 1960 | 0.340 |
Why?
|
Fibrosis | 6 | 2017 | 333 | 0.340 |
Why?
|
Hyperoxia | 1 | 2006 | 78 | 0.340 |
Why?
|
Base Sequence | 6 | 2017 | 2480 | 0.340 |
Why?
|
Complement Activation | 2 | 2007 | 269 | 0.340 |
Why?
|
Arteriosclerosis | 2 | 2004 | 125 | 0.340 |
Why?
|
Public Health | 1 | 2010 | 336 | 0.340 |
Why?
|
Extracellular Matrix | 3 | 2014 | 320 | 0.330 |
Why?
|
Transforming Growth Factor beta1 | 6 | 2007 | 158 | 0.330 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 402 | 0.330 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 5 | 2013 | 930 | 0.330 |
Why?
|
Environmental Health | 1 | 2005 | 31 | 0.320 |
Why?
|
Age Factors | 9 | 2019 | 3148 | 0.320 |
Why?
|
Organizational Objectives | 1 | 2005 | 73 | 0.320 |
Why?
|
Spirometry | 8 | 2015 | 214 | 0.320 |
Why?
|
Pregnancy | 7 | 2018 | 4488 | 0.320 |
Why?
|
Genetic Markers | 4 | 2014 | 424 | 0.320 |
Why?
|
Mice, Inbred DBA | 4 | 2008 | 213 | 0.320 |
Why?
|
Precision Medicine | 3 | 2018 | 226 | 0.320 |
Why?
|
Dietary Supplements | 1 | 2008 | 380 | 0.320 |
Why?
|
Culture Media | 4 | 2018 | 160 | 0.320 |
Why?
|
Linkage Disequilibrium | 3 | 2016 | 311 | 0.320 |
Why?
|
Gram-Negative Bacteria | 3 | 2018 | 65 | 0.320 |
Why?
|
Congresses as Topic | 3 | 2018 | 190 | 0.310 |
Why?
|
Acute-Phase Proteins | 1 | 2004 | 59 | 0.310 |
Why?
|
Environmental Illness | 1 | 2004 | 2 | 0.310 |
Why?
|
Inflammation Mediators | 5 | 2019 | 509 | 0.310 |
Why?
|
Pleura | 3 | 1994 | 22 | 0.300 |
Why?
|
Epigenomics | 2 | 2017 | 53 | 0.300 |
Why?
|
Regression Analysis | 6 | 2017 | 1179 | 0.300 |
Why?
|
Quantitative Trait, Heritable | 1 | 2005 | 139 | 0.300 |
Why?
|
Interleukin-13 | 4 | 2019 | 130 | 0.300 |
Why?
|
Enterobacteriaceae Infections | 3 | 2013 | 30 | 0.300 |
Why?
|
Interleukin-8 | 7 | 2009 | 257 | 0.300 |
Why?
|
Immunosuppressive Agents | 4 | 2020 | 836 | 0.290 |
Why?
|
Pneumonia, Bacterial | 1 | 2004 | 100 | 0.290 |
Why?
|
Cell Movement | 2 | 2007 | 889 | 0.290 |
Why?
|
Chagas Cardiomyopathy | 2 | 2015 | 20 | 0.290 |
Why?
|
Survival Analysis | 4 | 2015 | 1390 | 0.290 |
Why?
|
Alveolar Epithelial Cells | 3 | 2019 | 76 | 0.290 |
Why?
|
Proportional Hazards Models | 7 | 2019 | 1072 | 0.280 |
Why?
|
Gene Regulatory Networks | 2 | 2016 | 193 | 0.280 |
Why?
|
Genetic Linkage | 3 | 2011 | 403 | 0.280 |
Why?
|
Interleukin-6 | 9 | 2009 | 654 | 0.280 |
Why?
|
Bacteroides fragilis | 1 | 2002 | 9 | 0.280 |
Why?
|
Hypersensitivity, Immediate | 2 | 2008 | 51 | 0.280 |
Why?
|
Pleural Diseases | 3 | 1993 | 21 | 0.280 |
Why?
|
Mucins | 3 | 2019 | 67 | 0.270 |
Why?
|
Transcription, Genetic | 4 | 2013 | 1459 | 0.270 |
Why?
|
ROC Curve | 3 | 2019 | 455 | 0.270 |
Why?
|
CD11b Antigen | 1 | 2002 | 66 | 0.270 |
Why?
|
Microbiota | 3 | 2018 | 415 | 0.270 |
Why?
|
Pedigree | 7 | 2019 | 523 | 0.270 |
Why?
|
Proteome | 2 | 2017 | 266 | 0.270 |
Why?
|
Gene Frequency | 6 | 2013 | 557 | 0.270 |
Why?
|
Chronic Disease | 7 | 2017 | 1666 | 0.270 |
Why?
|
Obstetric Labor, Premature | 1 | 2002 | 46 | 0.270 |
Why?
|
Bacterial Infections | 6 | 2013 | 232 | 0.270 |
Why?
|
Chemokine CXCL2 | 5 | 2001 | 54 | 0.270 |
Why?
|
Bacteremia | 3 | 2013 | 156 | 0.260 |
Why?
|
Adolescent | 19 | 2019 | 16711 | 0.260 |
Why?
|
Eosinophils | 5 | 2015 | 238 | 0.260 |
Why?
|
Monokines | 5 | 2000 | 25 | 0.260 |
Why?
|
Retrospective Studies | 8 | 2017 | 9395 | 0.260 |
Why?
|
DNA Mutational Analysis | 6 | 2017 | 442 | 0.260 |
Why?
|
Kidney Transplantation | 1 | 2006 | 411 | 0.260 |
Why?
|
Telomere | 3 | 2019 | 199 | 0.260 |
Why?
|
Microbial Sensitivity Tests | 4 | 2018 | 269 | 0.250 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 82 | 0.250 |
Why?
|
Arthritis, Rheumatoid | 3 | 2018 | 792 | 0.250 |
Why?
|
Carbapenems | 2 | 2011 | 15 | 0.250 |
Why?
|
E2F1 Transcription Factor | 2 | 2012 | 59 | 0.250 |
Why?
|
Child | 10 | 2019 | 14709 | 0.250 |
Why?
|
Fibrinolysis | 1 | 2003 | 155 | 0.250 |
Why?
|
Kaplan-Meier Estimate | 3 | 2017 | 863 | 0.250 |
Why?
|
Receptors, Interleukin-1 | 4 | 2010 | 239 | 0.240 |
Why?
|
Survival Rate | 7 | 2019 | 1697 | 0.240 |
Why?
|
Constriction, Pathologic | 2 | 2020 | 163 | 0.240 |
Why?
|
Veterans | 4 | 2004 | 633 | 0.240 |
Why?
|
Phagocytosis | 3 | 2013 | 302 | 0.240 |
Why?
|
Swine | 5 | 2014 | 681 | 0.240 |
Why?
|
Blotting, Western | 4 | 2013 | 1427 | 0.240 |
Why?
|
Chemokines | 4 | 2012 | 212 | 0.240 |
Why?
|
Acute Disease | 5 | 2017 | 952 | 0.230 |
Why?
|
Infant, Newborn | 5 | 2018 | 4523 | 0.230 |
Why?
|
Telomere Homeostasis | 2 | 2017 | 27 | 0.230 |
Why?
|
Receptor for Advanced Glycation End Products | 2 | 2017 | 33 | 0.230 |
Why?
|
Genetic Association Studies | 4 | 2015 | 342 | 0.230 |
Why?
|
Prospective Studies | 15 | 2019 | 5256 | 0.230 |
Why?
|
Isoenzymes | 1 | 2001 | 378 | 0.230 |
Why?
|
Keratin-15 | 1 | 2019 | 12 | 0.230 |
Why?
|
Warfare | 1 | 2000 | 64 | 0.230 |
Why?
|
Odds Ratio | 5 | 2018 | 1036 | 0.220 |
Why?
|
Longitudinal Studies | 7 | 2017 | 2410 | 0.220 |
Why?
|
Bronchoalveolar Lavage | 3 | 2014 | 93 | 0.220 |
Why?
|
Reproducibility of Results | 8 | 2018 | 2596 | 0.220 |
Why?
|
Dilatation | 1 | 2020 | 39 | 0.220 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2020 | 176 | 0.220 |
Why?
|
Particulate Matter | 3 | 2009 | 145 | 0.220 |
Why?
|
Transforming Growth Factor beta | 4 | 2003 | 462 | 0.220 |
Why?
|
Interferon-beta | 2 | 2011 | 88 | 0.220 |
Why?
|
Lymphocyte Subsets | 1 | 2019 | 80 | 0.220 |
Why?
|
Chromosomes | 3 | 2008 | 81 | 0.220 |
Why?
|
Interleukin-5 Receptor alpha Subunit | 1 | 2018 | 3 | 0.220 |
Why?
|
Carrier Proteins | 1 | 2004 | 824 | 0.220 |
Why?
|
ERG1 Potassium Channel | 1 | 2018 | 3 | 0.220 |
Why?
|
Colloids | 1 | 2019 | 67 | 0.220 |
Why?
|
Staphylococcal Infections | 2 | 2016 | 315 | 0.220 |
Why?
|
alpha-Macroglobulins | 1 | 2019 | 26 | 0.220 |
Why?
|
MicroRNAs | 3 | 2014 | 581 | 0.220 |
Why?
|
Expectorants | 1 | 2018 | 15 | 0.210 |
Why?
|
Smoking Cessation | 2 | 2020 | 331 | 0.210 |
Why?
|
Spleen | 3 | 2012 | 569 | 0.210 |
Why?
|
Anti-Bacterial Agents | 5 | 2018 | 1190 | 0.210 |
Why?
|
Colistin | 1 | 2018 | 6 | 0.210 |
Why?
|
Adipokines | 1 | 2019 | 34 | 0.210 |
Why?
|
Interleukin-4 | 2 | 2015 | 242 | 0.210 |
Why?
|
Fucosyltransferases | 1 | 2018 | 19 | 0.210 |
Why?
|
Interleukin-12 | 1 | 1999 | 105 | 0.210 |
Why?
|
Infant, Premature | 1 | 2002 | 414 | 0.210 |
Why?
|
Exoribonucleases | 1 | 2019 | 41 | 0.210 |
Why?
|
Proteins | 4 | 2015 | 984 | 0.210 |
Why?
|
Mucous Membrane | 1 | 2019 | 115 | 0.210 |
Why?
|
Nasal Lavage Fluid | 2 | 2009 | 8 | 0.210 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2019 | 129 | 0.210 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2019 | 88 | 0.200 |
Why?
|
Colorado | 2 | 2019 | 4220 | 0.200 |
Why?
|
Time Factors | 12 | 2018 | 7055 | 0.200 |
Why?
|
Cells, Cultured | 9 | 2018 | 4327 | 0.200 |
Why?
|
Lymphocytes | 4 | 2008 | 369 | 0.200 |
Why?
|
Mass Screening | 2 | 2018 | 866 | 0.200 |
Why?
|
Sri Lanka | 1 | 2018 | 13 | 0.200 |
Why?
|
Rhodobacter sphaeroides | 1 | 1998 | 6 | 0.200 |
Why?
|
A549 Cells | 1 | 2018 | 44 | 0.200 |
Why?
|
Telomere-Binding Proteins | 1 | 2019 | 82 | 0.200 |
Why?
|
Oligonucleotides | 1 | 1999 | 149 | 0.200 |
Why?
|
Triamcinolone Acetonide | 1 | 1998 | 21 | 0.200 |
Why?
|
Macrophage Activation | 4 | 2011 | 140 | 0.200 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 2 | 2008 | 69 | 0.200 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 3 | 2018 | 54 | 0.200 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2019 | 132 | 0.200 |
Why?
|
Anti-Inflammatory Agents | 2 | 2000 | 421 | 0.200 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2020 | 144 | 0.200 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2017 | 34 | 0.200 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 2017 | 11 | 0.190 |
Why?
|
Betaine | 1 | 2018 | 63 | 0.190 |
Why?
|
Early Diagnosis | 1 | 2019 | 209 | 0.190 |
Why?
|
Nicotine | 1 | 2020 | 250 | 0.190 |
Why?
|
Pentoxifylline | 1 | 1997 | 18 | 0.190 |
Why?
|
Dinucleoside Phosphates | 1 | 1997 | 28 | 0.190 |
Why?
|
Fibroblasts | 2 | 2018 | 813 | 0.190 |
Why?
|
Mendelian Randomization Analysis | 1 | 2017 | 18 | 0.190 |
Why?
|
Severity of Illness Index | 6 | 2020 | 2554 | 0.190 |
Why?
|
Adoptive Transfer | 3 | 2009 | 256 | 0.190 |
Why?
|
Environmental Pollutants | 2 | 2011 | 72 | 0.190 |
Why?
|
Arrestins | 2 | 2009 | 20 | 0.190 |
Why?
|
Bronchoconstrictor Agents | 4 | 2011 | 22 | 0.190 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 807 | 0.180 |
Why?
|
RNA, Small Interfering | 2 | 2017 | 585 | 0.180 |
Why?
|
Sex Factors | 7 | 2018 | 1887 | 0.180 |
Why?
|
Administration, Intranasal | 1 | 2017 | 84 | 0.180 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2017 | 138 | 0.180 |
Why?
|
Flow Cytometry | 3 | 2013 | 1183 | 0.180 |
Why?
|
Gastroesophageal Reflux | 1 | 2019 | 214 | 0.180 |
Why?
|
Protein Binding | 2 | 2017 | 2108 | 0.180 |
Why?
|
A Kinase Anchor Proteins | 1 | 2017 | 79 | 0.180 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 1997 | 99 | 0.180 |
Why?
|
Prognosis | 6 | 2019 | 3108 | 0.180 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2009 | 342 | 0.180 |
Why?
|
Immunity, Humoral | 1 | 2017 | 85 | 0.180 |
Why?
|
Cell Adhesion | 3 | 2014 | 424 | 0.180 |
Why?
|
Esophagectomy | 1 | 2017 | 59 | 0.180 |
Why?
|
Pulmonary Diffusing Capacity | 7 | 2005 | 55 | 0.180 |
Why?
|
Biological Products | 1 | 2017 | 97 | 0.180 |
Why?
|
Trypanosoma cruzi | 2 | 2015 | 25 | 0.170 |
Why?
|
Gram-Positive Bacteria | 1 | 2016 | 49 | 0.170 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2016 | 76 | 0.170 |
Why?
|
Interferon-alpha | 1 | 1997 | 188 | 0.170 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 299 | 0.170 |
Why?
|
Molecular Sequence Data | 7 | 2011 | 3507 | 0.170 |
Why?
|
Communicable Diseases | 1 | 2017 | 95 | 0.170 |
Why?
|
Extracellular Matrix Proteins | 2 | 2007 | 124 | 0.170 |
Why?
|
Down-Regulation | 1 | 2019 | 702 | 0.170 |
Why?
|
Skin Diseases | 1 | 2017 | 150 | 0.170 |
Why?
|
Carbon Monoxide | 2 | 2012 | 68 | 0.170 |
Why?
|
Air Pollution | 1 | 2017 | 125 | 0.170 |
Why?
|
Binding Sites | 2 | 2017 | 1344 | 0.170 |
Why?
|
Peak Expiratory Flow Rate | 1 | 1995 | 36 | 0.170 |
Why?
|
Central Nervous System Stimulants | 1 | 2017 | 148 | 0.170 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2015 | 5 | 0.170 |
Why?
|
Plasma | 1 | 2017 | 212 | 0.170 |
Why?
|
Pseudomonas aeruginosa | 3 | 2009 | 298 | 0.170 |
Why?
|
Antigens, Dermatophagoides | 2 | 2014 | 15 | 0.170 |
Why?
|
Self Care | 1 | 2018 | 357 | 0.170 |
Why?
|
Hydrocortisone | 1 | 1998 | 293 | 0.160 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2008 | 142 | 0.160 |
Why?
|
Global Health | 1 | 2018 | 301 | 0.160 |
Why?
|
Transplantation, Homologous | 3 | 2007 | 506 | 0.160 |
Why?
|
Interleukin-1 Receptor-Like 1 Protein | 1 | 2015 | 22 | 0.160 |
Why?
|
Radiography | 5 | 2005 | 860 | 0.160 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 1177 | 0.160 |
Why?
|
Immunity, Cellular | 1 | 2017 | 298 | 0.160 |
Why?
|
Computational Biology | 3 | 2009 | 529 | 0.160 |
Why?
|
Trachea | 3 | 2009 | 226 | 0.160 |
Why?
|
Cell Division | 4 | 2004 | 888 | 0.160 |
Why?
|
Risk | 3 | 2015 | 938 | 0.160 |
Why?
|
Pilot Projects | 2 | 2020 | 1250 | 0.160 |
Why?
|
Esophageal Neoplasms | 1 | 2017 | 193 | 0.160 |
Why?
|
Acetylcysteine | 1 | 2015 | 137 | 0.160 |
Why?
|
Mice, 129 Strain | 2 | 2012 | 97 | 0.160 |
Why?
|
Real-Time Polymerase Chain Reaction | 2 | 2013 | 382 | 0.160 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 1445 | 0.160 |
Why?
|
Antigens, Protozoan | 2 | 2012 | 20 | 0.160 |
Why?
|
NF-kappa B | 3 | 2014 | 688 | 0.150 |
Why?
|
Asian Continental Ancestry Group | 1 | 2015 | 154 | 0.150 |
Why?
|
Isoleucine | 1 | 2014 | 18 | 0.150 |
Why?
|
Threonine | 1 | 2014 | 44 | 0.150 |
Why?
|
RNA Polymerase II | 1 | 2017 | 267 | 0.150 |
Why?
|
Research | 4 | 2005 | 436 | 0.150 |
Why?
|
Recombinant Fusion Proteins | 2 | 2008 | 688 | 0.150 |
Why?
|
Microscopy, Fluorescence | 2 | 2013 | 435 | 0.150 |
Why?
|
Homeostasis | 3 | 2009 | 495 | 0.150 |
Why?
|
Ribonucleoprotein, U5 Small Nuclear | 1 | 2013 | 12 | 0.150 |
Why?
|
Peptide Elongation Factors | 1 | 2013 | 7 | 0.150 |
Why?
|
Macrophage Migration-Inhibitory Factors | 1 | 2013 | 12 | 0.150 |
Why?
|
Reconstructive Surgical Procedures | 1 | 2017 | 240 | 0.150 |
Why?
|
Gene-Environment Interaction | 2 | 2014 | 197 | 0.150 |
Why?
|
Interleukins | 1 | 1996 | 214 | 0.150 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 1187 | 0.150 |
Why?
|
Algorithms | 2 | 2019 | 1409 | 0.150 |
Why?
|
beta-Lactamases | 2 | 2005 | 26 | 0.150 |
Why?
|
Telemedicine | 1 | 2018 | 319 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2015 | 457 | 0.150 |
Why?
|
Intramolecular Oxidoreductases | 1 | 2013 | 68 | 0.150 |
Why?
|
HLA-A Antigens | 1 | 1993 | 44 | 0.150 |
Why?
|
Vehicle Emissions | 1 | 2013 | 54 | 0.140 |
Why?
|
HLA-B Antigens | 1 | 1993 | 43 | 0.140 |
Why?
|
Treatment Outcome | 5 | 2020 | 8377 | 0.140 |
Why?
|
Heterozygote | 5 | 2016 | 284 | 0.140 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2014 | 197 | 0.140 |
Why?
|
Glucocorticoids | 1 | 1998 | 492 | 0.140 |
Why?
|
Iowa | 4 | 2004 | 29 | 0.140 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2015 | 695 | 0.140 |
Why?
|
Chromosomes, Human | 1 | 2013 | 60 | 0.140 |
Why?
|
Coal Ash | 2 | 2004 | 4 | 0.140 |
Why?
|
Pulmonary Surfactants | 3 | 2016 | 108 | 0.140 |
Why?
|
Membrane Proteins | 3 | 2016 | 1111 | 0.140 |
Why?
|
Hedgehog Proteins | 2 | 2013 | 158 | 0.140 |
Why?
|
Epithelium | 2 | 2009 | 288 | 0.140 |
Why?
|
Protein Interaction Maps | 1 | 2012 | 29 | 0.140 |
Why?
|
Myocardial Contraction | 1 | 2015 | 368 | 0.140 |
Why?
|
Proto-Oncogene Proteins | 1 | 2017 | 705 | 0.140 |
Why?
|
Bone Marrow | 2 | 2010 | 236 | 0.140 |
Why?
|
Tobacco | 1 | 2013 | 138 | 0.130 |
Why?
|
Dyspnea | 5 | 2005 | 162 | 0.130 |
Why?
|
HLA-DQ Antigens | 1 | 1993 | 183 | 0.130 |
Why?
|
H-2 Antigens | 1 | 2012 | 88 | 0.130 |
Why?
|
Solubility | 2 | 2017 | 279 | 0.130 |
Why?
|
HLA-DR Antigens | 1 | 1993 | 223 | 0.130 |
Why?
|
Physical Exertion | 1 | 1994 | 275 | 0.130 |
Why?
|
Histamine | 1 | 1992 | 58 | 0.130 |
Why?
|
Depression | 2 | 2018 | 934 | 0.130 |
Why?
|
Myocarditis | 1 | 2012 | 72 | 0.130 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 290 | 0.130 |
Why?
|
Transcription Factors | 3 | 2015 | 1581 | 0.130 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2012 | 69 | 0.130 |
Why?
|
Cell Separation | 1 | 2013 | 313 | 0.130 |
Why?
|
Aluminum Silicates | 1 | 1991 | 26 | 0.130 |
Why?
|
Observer Variation | 1 | 2012 | 347 | 0.130 |
Why?
|
beta-Lactam Resistance | 1 | 2011 | 9 | 0.130 |
Why?
|
Collagen | 2 | 2006 | 391 | 0.120 |
Why?
|
Pulmonary Ventilation | 3 | 1997 | 88 | 0.120 |
Why?
|
Carbon | 2 | 2004 | 154 | 0.120 |
Why?
|
Finland | 2 | 2019 | 57 | 0.120 |
Why?
|
Cross-Over Studies | 3 | 1998 | 466 | 0.120 |
Why?
|
Cross-Sectional Studies | 6 | 2018 | 3359 | 0.120 |
Why?
|
Proteomics | 3 | 2017 | 655 | 0.120 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 469 | 0.120 |
Why?
|
Sensitivity and Specificity | 5 | 2011 | 1885 | 0.120 |
Why?
|
Hospitalization | 2 | 2017 | 1335 | 0.120 |
Why?
|
Killer Cells, Natural | 1 | 2013 | 381 | 0.120 |
Why?
|
Immunocompromised Host | 1 | 2012 | 192 | 0.120 |
Why?
|
Escherichia coli Infections | 1 | 2011 | 121 | 0.120 |
Why?
|
African Americans | 1 | 2016 | 977 | 0.120 |
Why?
|
Nitric Oxide | 3 | 2014 | 840 | 0.120 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2010 | 19 | 0.120 |
Why?
|
Melanoma | 1 | 2017 | 640 | 0.120 |
Why?
|
Accidents, Occupational | 1 | 1990 | 32 | 0.110 |
Why?
|
Drug Resistance, Bacterial | 1 | 2011 | 142 | 0.110 |
Why?
|
Paternal Age | 1 | 1989 | 4 | 0.110 |
Why?
|
Amino Acid Sequence | 4 | 2011 | 2530 | 0.110 |
Why?
|
Chlorine | 1 | 1990 | 56 | 0.110 |
Why?
|
Cystic Fibrosis | 1 | 1997 | 676 | 0.110 |
Why?
|
Serratia marcescens | 1 | 2009 | 16 | 0.110 |
Why?
|
Gases | 1 | 1990 | 59 | 0.110 |
Why?
|
Caspases | 1 | 2011 | 291 | 0.110 |
Why?
|
Chemokine CXCL1 | 1 | 2009 | 70 | 0.110 |
Why?
|
Repressor Proteins | 1 | 2013 | 364 | 0.110 |
Why?
|
Metallothionein | 1 | 2009 | 26 | 0.110 |
Why?
|
Sus scrofa | 1 | 2009 | 49 | 0.110 |
Why?
|
Growth Substances | 1 | 1989 | 151 | 0.110 |
Why?
|
Acute Lung Injury | 1 | 2013 | 297 | 0.110 |
Why?
|
Chemotaxis, Leukocyte | 2 | 2012 | 114 | 0.110 |
Why?
|
Iceland | 2 | 2019 | 14 | 0.110 |
Why?
|
Mice, Inbred AKR | 1 | 2008 | 26 | 0.100 |
Why?
|
Mice, Inbred NZB | 1 | 2008 | 21 | 0.100 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2009 | 84 | 0.100 |
Why?
|
Mice, Inbred A | 1 | 2008 | 49 | 0.100 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2008 | 40 | 0.100 |
Why?
|
Feces | 1 | 2011 | 348 | 0.100 |
Why?
|
Genome | 1 | 2011 | 248 | 0.100 |
Why?
|
Procollagen | 1 | 2008 | 19 | 0.100 |
Why?
|
Aspergillus fumigatus | 1 | 2008 | 20 | 0.100 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 302 | 0.100 |
Why?
|
Forkhead Transcription Factors | 1 | 2009 | 187 | 0.100 |
Why?
|
Gene Library | 1 | 2008 | 122 | 0.100 |
Why?
|
Azacitidine | 1 | 2008 | 75 | 0.100 |
Why?
|
Nitric Oxide Synthase | 2 | 2006 | 245 | 0.100 |
Why?
|
Software | 1 | 2012 | 525 | 0.100 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2004 | 465 | 0.100 |
Why?
|
Paint | 1 | 1988 | 7 | 0.100 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2008 | 184 | 0.100 |
Why?
|
Bacteria | 1 | 2014 | 632 | 0.100 |
Why?
|
Immune Complex Diseases | 1 | 2007 | 9 | 0.100 |
Why?
|
Chemokine CCL5 | 1 | 2007 | 36 | 0.100 |
Why?
|
Chemotactic Factors | 2 | 1998 | 37 | 0.100 |
Why?
|
Infant | 4 | 2019 | 7300 | 0.100 |
Why?
|
Brachiocephalic Veins | 1 | 2007 | 7 | 0.100 |
Why?
|
Adenoviridae | 2 | 2006 | 207 | 0.100 |
Why?
|
Predictive Value of Tests | 5 | 2015 | 1874 | 0.100 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2008 | 133 | 0.100 |
Why?
|
Bronchoscopy | 3 | 2014 | 231 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 979 | 0.100 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2004 | 482 | 0.090 |
Why?
|
Cytokinesis | 1 | 2007 | 38 | 0.090 |
Why?
|
Liver | 3 | 2012 | 1744 | 0.090 |
Why?
|
Dinoprostone | 2 | 2001 | 186 | 0.090 |
Why?
|
Lung Compliance | 1 | 2007 | 52 | 0.090 |
Why?
|
Protein Interaction Mapping | 1 | 2008 | 114 | 0.090 |
Why?
|
Recombination, Genetic | 2 | 2005 | 193 | 0.090 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2007 | 30 | 0.090 |
Why?
|
Graft Occlusion, Vascular | 1 | 2007 | 46 | 0.090 |
Why?
|
Apoptosis | 2 | 2008 | 2532 | 0.090 |
Why?
|
Placebos | 2 | 1998 | 210 | 0.090 |
Why?
|
Up-Regulation | 3 | 2013 | 977 | 0.090 |
Why?
|
Arm | 1 | 2007 | 87 | 0.090 |
Why?
|
Ligands | 2 | 2011 | 528 | 0.090 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 2008 | 96 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2013 | 539 | 0.090 |
Why?
|
Single-Blind Method | 2 | 1998 | 268 | 0.090 |
Why?
|
Crosses, Genetic | 2 | 2011 | 154 | 0.090 |
Why?
|
Monocytes | 1 | 1989 | 441 | 0.090 |
Why?
|
Cluster Analysis | 3 | 2014 | 444 | 0.090 |
Why?
|
Chemokine CCL2 | 1 | 2007 | 132 | 0.090 |
Why?
|
Aerosols | 2 | 2001 | 152 | 0.090 |
Why?
|
Chemokines, CXC | 1 | 2006 | 66 | 0.090 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2007 | 80 | 0.090 |
Why?
|
Chimera | 1 | 2006 | 54 | 0.090 |
Why?
|
Neutrophil Activation | 1 | 2007 | 103 | 0.090 |
Why?
|
Tumor Cells, Cultured | 2 | 2001 | 1019 | 0.090 |
Why?
|
Double-Blind Method | 4 | 2005 | 1508 | 0.090 |
Why?
|
Societies, Medical | 2 | 2018 | 708 | 0.090 |
Why?
|
Receptors, CXCR4 | 1 | 2006 | 72 | 0.090 |
Why?
|
Organ Specificity | 1 | 2007 | 321 | 0.090 |
Why?
|
Ear, Middle | 2 | 2018 | 56 | 0.090 |
Why?
|
Chemokine CXCL12 | 1 | 2006 | 79 | 0.090 |
Why?
|
Brachial Artery | 1 | 2007 | 173 | 0.090 |
Why?
|
Lymphokines | 1 | 2006 | 138 | 0.090 |
Why?
|
Nitrites | 1 | 2006 | 78 | 0.090 |
Why?
|
Gene Deletion | 2 | 2012 | 401 | 0.090 |
Why?
|
Rural Population | 1 | 2009 | 354 | 0.090 |
Why?
|
Recombinant Proteins | 3 | 2005 | 1454 | 0.090 |
Why?
|
Blood | 2 | 2005 | 97 | 0.090 |
Why?
|
Cell Count | 2 | 1998 | 358 | 0.090 |
Why?
|
Cell Culture Techniques | 1 | 2008 | 313 | 0.090 |
Why?
|
Body Mass Index | 2 | 2015 | 1980 | 0.090 |
Why?
|
Response Elements | 1 | 2006 | 81 | 0.090 |
Why?
|
Protein Subunits | 1 | 2007 | 247 | 0.090 |
Why?
|
Postal Service | 2 | 1996 | 30 | 0.090 |
Why?
|
Interferons | 1 | 2006 | 96 | 0.090 |
Why?
|
Agar | 2 | 2018 | 10 | 0.080 |
Why?
|
Histones | 1 | 2011 | 501 | 0.080 |
Why?
|
Child, Preschool | 3 | 2019 | 8785 | 0.080 |
Why?
|
Learning | 1 | 1989 | 324 | 0.080 |
Why?
|
S-Nitrosothiols | 1 | 2005 | 7 | 0.080 |
Why?
|
S-Nitrosoglutathione | 1 | 2005 | 9 | 0.080 |
Why?
|
Genes, Recessive | 1 | 2005 | 79 | 0.080 |
Why?
|
Glutathione Reductase | 1 | 2005 | 31 | 0.080 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2005 | 124 | 0.080 |
Why?
|
Saskatchewan | 2 | 2018 | 5 | 0.080 |
Why?
|
Wnt Proteins | 1 | 2006 | 146 | 0.080 |
Why?
|
Transplantation, Heterotopic | 1 | 2005 | 32 | 0.080 |
Why?
|
Chimerism | 1 | 2004 | 14 | 0.080 |
Why?
|
T-Lymphocytes | 3 | 2009 | 1627 | 0.080 |
Why?
|
Genetic Vectors | 1 | 2006 | 307 | 0.080 |
Why?
|
Tryptophan Hydroxylase | 1 | 2005 | 46 | 0.080 |
Why?
|
Enzyme Activation | 1 | 2007 | 986 | 0.080 |
Why?
|
Population Surveillance | 2 | 2000 | 386 | 0.080 |
Why?
|
Lymphocyte Count | 1 | 2004 | 148 | 0.080 |
Why?
|
Patient Compliance | 2 | 2020 | 598 | 0.080 |
Why?
|
Body Temperature | 1 | 2006 | 282 | 0.080 |
Why?
|
Amino Acid Substitution | 2 | 2005 | 306 | 0.080 |
Why?
|
I-kappa B Kinase | 1 | 2004 | 51 | 0.080 |
Why?
|
Models, Biological | 3 | 2013 | 1797 | 0.080 |
Why?
|
Methotrexate | 2 | 1996 | 229 | 0.080 |
Why?
|
Oxidative Stress | 2 | 2009 | 1130 | 0.080 |
Why?
|
Phosphorylation | 1 | 2009 | 1785 | 0.080 |
Why?
|
Sputum | 2 | 1997 | 250 | 0.080 |
Why?
|
Renal Dialysis | 1 | 2007 | 293 | 0.080 |
Why?
|
Mice, Mutant Strains | 2 | 2003 | 326 | 0.080 |
Why?
|
Peroxidase | 1 | 2004 | 193 | 0.080 |
Why?
|
Neoplasms | 1 | 2017 | 1822 | 0.080 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2004 | 28 | 0.080 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2016 | 221 | 0.080 |
Why?
|
Microsatellite Repeats | 1 | 2005 | 177 | 0.080 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 349 | 0.080 |
Why?
|
Molecular Biology | 1 | 2004 | 73 | 0.080 |
Why?
|
DNA, Mitochondrial | 1 | 2005 | 167 | 0.080 |
Why?
|
Evolution, Molecular | 1 | 2008 | 451 | 0.080 |
Why?
|
Fever | 1 | 2006 | 290 | 0.080 |
Why?
|
Research Support as Topic | 1 | 2005 | 115 | 0.080 |
Why?
|
Biology | 1 | 2004 | 44 | 0.070 |
Why?
|
Trypanosoma brucei brucei | 1 | 2003 | 8 | 0.070 |
Why?
|
Pulmonary Edema | 1 | 2004 | 161 | 0.070 |
Why?
|
Probability | 1 | 2005 | 332 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 955 | 0.070 |
Why?
|
DNA, Protozoan | 1 | 2003 | 30 | 0.070 |
Why?
|
Plethysmography | 1 | 2004 | 123 | 0.070 |
Why?
|
Protein-Serine-Threonine Kinases | 2 | 2005 | 603 | 0.070 |
Why?
|
Models, Genetic | 1 | 2007 | 680 | 0.070 |
Why?
|
Therapeutic Irrigation | 1 | 2003 | 61 | 0.070 |
Why?
|
Bronchitis, Chronic | 1 | 2003 | 19 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2007 | 378 | 0.070 |
Why?
|
Interleukin-5 | 1 | 2003 | 27 | 0.070 |
Why?
|
Drug Resistance | 1 | 2004 | 199 | 0.070 |
Why?
|
Petroleum | 1 | 2002 | 8 | 0.070 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2003 | 84 | 0.070 |
Why?
|
CD18 Antigens | 1 | 2002 | 34 | 0.070 |
Why?
|
Teichoic Acids | 1 | 2002 | 14 | 0.070 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2002 | 13 | 0.070 |
Why?
|
Cyclophosphamide | 2 | 1994 | 222 | 0.070 |
Why?
|
Geographic Information Systems | 1 | 2002 | 34 | 0.070 |
Why?
|
HEK293 Cells | 2 | 2018 | 589 | 0.070 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 839 | 0.070 |
Why?
|
Bronchitis | 1 | 2002 | 50 | 0.070 |
Why?
|
Proteolipids | 1 | 2002 | 27 | 0.070 |
Why?
|
Skin Tests | 2 | 2008 | 141 | 0.070 |
Why?
|
DNA Damage | 1 | 2005 | 345 | 0.070 |
Why?
|
Genetic Testing | 3 | 2017 | 353 | 0.070 |
Why?
|
Lymphocyte Activation | 1 | 2007 | 1218 | 0.070 |
Why?
|
Nitric Oxide Synthase Type II | 3 | 2010 | 176 | 0.070 |
Why?
|
Combat Disorders | 1 | 2002 | 31 | 0.070 |
Why?
|
Dermatitis, Atopic | 1 | 2005 | 254 | 0.070 |
Why?
|
Carcinogens | 1 | 2002 | 116 | 0.070 |
Why?
|
Plethysmography, Whole Body | 1 | 2001 | 1 | 0.070 |
Why?
|
Serotonin | 1 | 2005 | 348 | 0.070 |
Why?
|
Carotid Artery Diseases | 1 | 2002 | 55 | 0.070 |
Why?
|
Causality | 1 | 2002 | 93 | 0.070 |
Why?
|
Cyclooxygenase 1 | 1 | 2001 | 28 | 0.060 |
Why?
|
Protease Inhibitors | 1 | 2002 | 92 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2005 | 265 | 0.060 |
Why?
|
Pulmonary Medicine | 1 | 2003 | 86 | 0.060 |
Why?
|
Epilepsies, Partial | 1 | 2001 | 26 | 0.060 |
Why?
|
Leukotriene B4 | 1 | 2001 | 64 | 0.060 |
Why?
|
Endothelial Cells | 1 | 2007 | 558 | 0.060 |
Why?
|
Wound Healing | 1 | 2004 | 298 | 0.060 |
Why?
|
Protein Structure, Tertiary | 2 | 2003 | 956 | 0.060 |
Why?
|
Heart Rate | 1 | 2006 | 799 | 0.060 |
Why?
|
Europe | 2 | 2017 | 312 | 0.060 |
Why?
|
Staphylococcus aureus | 2 | 2016 | 357 | 0.060 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2001 | 63 | 0.060 |
Why?
|
Anxiety Disorders | 1 | 2004 | 232 | 0.060 |
Why?
|
Lac Operon | 1 | 2001 | 53 | 0.060 |
Why?
|
Injections, Intravenous | 2 | 1999 | 268 | 0.060 |
Why?
|
Antigens, Surface | 1 | 2001 | 152 | 0.060 |
Why?
|
Middle East | 1 | 2000 | 8 | 0.060 |
Why?
|
Carotid Arteries | 1 | 2002 | 171 | 0.060 |
Why?
|
Cyclooxygenase 2 | 1 | 2001 | 198 | 0.060 |
Why?
|
Military Personnel | 2 | 2004 | 259 | 0.060 |
Why?
|
Haplotypes | 2 | 2014 | 540 | 0.060 |
Why?
|
Respiration, Artificial | 1 | 2004 | 478 | 0.060 |
Why?
|
Autoimmune Diseases | 1 | 2004 | 442 | 0.060 |
Why?
|
TATA Box Binding Protein-Like Proteins | 1 | 2019 | 2 | 0.060 |
Why?
|
Bupropion | 1 | 2020 | 28 | 0.060 |
Why?
|
Varenicline | 1 | 2020 | 18 | 0.060 |
Why?
|
beta Karyopherins | 1 | 2019 | 9 | 0.060 |
Why?
|
Trichinella spiralis | 1 | 2019 | 2 | 0.060 |
Why?
|
Cross Protection | 1 | 2019 | 2 | 0.060 |
Why?
|
Trichinellosis | 1 | 2019 | 5 | 0.060 |
Why?
|
Goblet Cells | 1 | 2019 | 21 | 0.060 |
Why?
|
Gestational Age | 1 | 2002 | 677 | 0.060 |
Why?
|
Evoked Potentials, Auditory | 1 | 2001 | 255 | 0.060 |
Why?
|
Linear Models | 2 | 2015 | 888 | 0.060 |
Why?
|
Mitochondria | 1 | 2005 | 684 | 0.050 |
Why?
|
Philippines | 1 | 2019 | 53 | 0.050 |
Why?
|
Myeloid Differentiation Factor 88 | 2 | 2013 | 107 | 0.050 |
Why?
|
Factor Analysis, Statistical | 1 | 2000 | 279 | 0.050 |
Why?
|
Pakistan | 1 | 2019 | 74 | 0.050 |
Why?
|
Point Mutation | 1 | 2000 | 264 | 0.050 |
Why?
|
Graft vs Host Disease | 1 | 2001 | 210 | 0.050 |
Why?
|
Virus Physiological Phenomena | 1 | 2018 | 6 | 0.050 |
Why?
|
Kinesin | 1 | 2020 | 88 | 0.050 |
Why?
|
Hyperplasia | 1 | 2019 | 176 | 0.050 |
Why?
|
Biopsy | 4 | 2012 | 1033 | 0.050 |
Why?
|
Spindle Apparatus | 1 | 2020 | 117 | 0.050 |
Why?
|
Blood Pressure | 1 | 2006 | 1585 | 0.050 |
Why?
|
Actins | 1 | 2001 | 377 | 0.050 |
Why?
|
Rural Health | 1 | 1999 | 91 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2007 | 2258 | 0.050 |
Why?
|
Transfection | 1 | 2001 | 1034 | 0.050 |
Why?
|
Homozygote | 2 | 2009 | 206 | 0.050 |
Why?
|
COS Cells | 1 | 2018 | 217 | 0.050 |
Why?
|
Consensus | 1 | 2020 | 285 | 0.050 |
Why?
|
Environmental Pollution | 1 | 2018 | 17 | 0.050 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2018 | 53 | 0.050 |
Why?
|
Premedication | 1 | 1998 | 41 | 0.050 |
Why?
|
Tertiary Lymphoid Structures | 1 | 2017 | 11 | 0.050 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1997 | 46 | 0.050 |
Why?
|
Rho Guanine Nucleotide Exchange Factors | 1 | 2017 | 22 | 0.050 |
Why?
|
Maternal Health | 1 | 2018 | 34 | 0.050 |
Why?
|
Disease-Free Survival | 1 | 2020 | 661 | 0.050 |
Why?
|
Ultrasonography | 1 | 2002 | 694 | 0.050 |
Why?
|
Exome | 1 | 2018 | 178 | 0.050 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2017 | 65 | 0.050 |
Why?
|
Carrier State | 1 | 1997 | 39 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2004 | 921 | 0.050 |
Why?
|
beta-Arrestin 2 | 2 | 2009 | 4 | 0.050 |
Why?
|
Pulmonary Gas Exchange | 2 | 1995 | 140 | 0.050 |
Why?
|
Child Health | 1 | 2018 | 54 | 0.050 |
Why?
|
beta-Arrestins | 2 | 2009 | 16 | 0.050 |
Why?
|
Text Messaging | 1 | 2018 | 97 | 0.050 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 321 | 0.050 |
Why?
|
Workflow | 1 | 2018 | 89 | 0.050 |
Why?
|
Penicillamine | 1 | 1996 | 26 | 0.050 |
Why?
|
Folic Acid | 1 | 2018 | 136 | 0.050 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 100 | 0.050 |
Why?
|
Polymyxin B | 1 | 1996 | 20 | 0.050 |
Why?
|
Conserved Sequence | 1 | 1997 | 241 | 0.050 |
Why?
|
Chemical Fractionation | 1 | 1996 | 31 | 0.040 |
Why?
|
Infusions, Intravenous | 1 | 1998 | 431 | 0.040 |
Why?
|
Intensive Care Units | 2 | 2010 | 496 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 63 | 0.040 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2016 | 91 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 1 | 2007 | 2761 | 0.040 |
Why?
|
I-kappa B Proteins | 1 | 2016 | 84 | 0.040 |
Why?
|
Microspheres | 1 | 1996 | 89 | 0.040 |
Why?
|
ADAMTS9 Protein | 1 | 2015 | 6 | 0.040 |
Why?
|
ADAMTS4 Protein | 1 | 2015 | 6 | 0.040 |
Why?
|
Serpin E2 | 1 | 2015 | 6 | 0.040 |
Why?
|
Procollagen N-Endopeptidase | 1 | 2015 | 8 | 0.040 |
Why?
|
Emphysema | 1 | 2016 | 92 | 0.040 |
Why?
|
Forecasting | 1 | 2018 | 360 | 0.040 |
Why?
|
Serpins | 1 | 2015 | 23 | 0.040 |
Why?
|
Pseudomonas Infections | 1 | 1997 | 165 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 532 | 0.040 |
Why?
|
E-Selectin | 1 | 2015 | 61 | 0.040 |
Why?
|
Gold | 1 | 1996 | 97 | 0.040 |
Why?
|
DNA Primers | 1 | 1997 | 647 | 0.040 |
Why?
|
Models, Animal | 1 | 2018 | 390 | 0.040 |
Why?
|
ADAM Proteins | 1 | 2015 | 62 | 0.040 |
Why?
|
Radiotherapy | 1 | 2017 | 206 | 0.040 |
Why?
|
Aspergillus oryzae | 1 | 2015 | 4 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2002 | 1255 | 0.040 |
Why?
|
Republic of Korea | 1 | 2015 | 22 | 0.040 |
Why?
|
Stents | 1 | 2020 | 438 | 0.040 |
Why?
|
Dermatophagoides pteronyssinus | 1 | 2014 | 3 | 0.040 |
Why?
|
Residual Volume | 2 | 1995 | 5 | 0.040 |
Why?
|
Cough | 1 | 1995 | 84 | 0.040 |
Why?
|
Kinetics | 1 | 1999 | 1831 | 0.040 |
Why?
|
Blood Cells | 1 | 2014 | 42 | 0.040 |
Why?
|
Respiratory Sounds | 1 | 1995 | 85 | 0.040 |
Why?
|
Treatment Failure | 2 | 2007 | 311 | 0.040 |
Why?
|
Mexico | 1 | 2015 | 161 | 0.040 |
Why?
|
Respiratory Dead Space | 1 | 1994 | 5 | 0.040 |
Why?
|
Agriculture | 1 | 1995 | 78 | 0.040 |
Why?
|
Bacterial Load | 1 | 2014 | 59 | 0.040 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 498 | 0.040 |
Why?
|
Genotyping Techniques | 1 | 2014 | 83 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2006 | 2027 | 0.040 |
Why?
|
Nebulizers and Vaporizers | 1 | 1994 | 72 | 0.040 |
Why?
|
Mass Chest X-Ray | 1 | 1994 | 3 | 0.040 |
Why?
|
Genetics | 1 | 2014 | 39 | 0.040 |
Why?
|
Antirheumatic Agents | 1 | 1996 | 232 | 0.040 |
Why?
|
Plant Extracts | 1 | 1996 | 174 | 0.040 |
Why?
|
Comparative Genomic Hybridization | 1 | 2013 | 37 | 0.040 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2013 | 34 | 0.040 |
Why?
|
HLA-B44 Antigen | 1 | 1993 | 2 | 0.040 |
Why?
|
HLA-DRB4 Chains | 1 | 1993 | 4 | 0.040 |
Why?
|
Soybeans | 1 | 1993 | 25 | 0.040 |
Why?
|
Random Allocation | 1 | 1995 | 398 | 0.040 |
Why?
|
Isotonic Solutions | 1 | 1993 | 47 | 0.040 |
Why?
|
Pyroglyphidae | 1 | 2013 | 17 | 0.040 |
Why?
|
APACHE | 1 | 2013 | 61 | 0.040 |
Why?
|
Immunoglobulin G | 2 | 2011 | 752 | 0.040 |
Why?
|
Toll-Like Receptor 1 | 1 | 2012 | 10 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2015 | 190 | 0.030 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2012 | 22 | 0.030 |
Why?
|
Equipment Design | 1 | 1995 | 536 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2013 | 135 | 0.030 |
Why?
|
Fibronectins | 1 | 1993 | 110 | 0.030 |
Why?
|
DNA Probes | 1 | 2012 | 76 | 0.030 |
Why?
|
Programming Languages | 1 | 2012 | 24 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 1999 | 687 | 0.030 |
Why?
|
Quality of Life | 2 | 2018 | 1711 | 0.030 |
Why?
|
Latin America | 1 | 2012 | 48 | 0.030 |
Why?
|
Blood Coagulation Factors | 1 | 2012 | 32 | 0.030 |
Why?
|
Urine | 1 | 1993 | 70 | 0.030 |
Why?
|
Multigene Family | 1 | 2013 | 227 | 0.030 |
Why?
|
Stem Cell Transplantation | 1 | 2013 | 142 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2013 | 195 | 0.030 |
Why?
|
Prednisone | 1 | 1993 | 227 | 0.030 |
Why?
|
Functional Residual Capacity | 1 | 1991 | 12 | 0.030 |
Why?
|
Brain | 1 | 2005 | 2612 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 635 | 0.030 |
Why?
|
Mast Cells | 1 | 1992 | 106 | 0.030 |
Why?
|
Databases, Factual | 1 | 2017 | 1085 | 0.030 |
Why?
|
Education | 1 | 2012 | 109 | 0.030 |
Why?
|
Urinary Tract Infections | 1 | 1993 | 119 | 0.030 |
Why?
|
Poly I-C | 1 | 2011 | 55 | 0.030 |
Why?
|
Arthropod Proteins | 1 | 2011 | 6 | 0.030 |
Why?
|
Lipoproteins | 1 | 2012 | 201 | 0.030 |
Why?
|
Antigens | 1 | 2013 | 305 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 1469 | 0.030 |
Why?
|
Blood Proteins | 1 | 2013 | 237 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 2011 | 75 | 0.030 |
Why?
|
Greece | 1 | 2010 | 5 | 0.030 |
Why?
|
Metallurgy | 1 | 1990 | 10 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 2012 | 449 | 0.030 |
Why?
|
Germany | 1 | 2010 | 72 | 0.030 |
Why?
|
Listeriosis | 1 | 2011 | 65 | 0.030 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 1 | 2010 | 52 | 0.030 |
Why?
|
Forced Expiratory Flow Rates | 1 | 2009 | 16 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2013 | 418 | 0.030 |
Why?
|
Listeria monocytogenes | 1 | 2011 | 93 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2011 | 393 | 0.030 |
Why?
|
Thrombosis | 1 | 2012 | 234 | 0.030 |
Why?
|
Postoperative Period | 1 | 2010 | 288 | 0.030 |
Why?
|
Nucleic Acid Hybridization | 1 | 1989 | 225 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2011 | 193 | 0.030 |
Why?
|
Registries | 1 | 2017 | 1648 | 0.030 |
Why?
|
Resuscitation | 1 | 1991 | 227 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2011 | 295 | 0.030 |
Why?
|
Helium | 1 | 2007 | 8 | 0.020 |
Why?
|
Biological Evolution | 1 | 2012 | 428 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2009 | 190 | 0.020 |
Why?
|
Calcium Phosphates | 1 | 2007 | 28 | 0.020 |
Why?
|
Platelet Count | 1 | 2007 | 85 | 0.020 |
Why?
|
Cross Infection | 1 | 2010 | 218 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2009 | 284 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2009 | 338 | 0.020 |
Why?
|
Reference Values | 1 | 1989 | 914 | 0.020 |
Why?
|
Particle Size | 1 | 2009 | 379 | 0.020 |
Why?
|
Health Surveys | 1 | 2009 | 482 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2007 | 116 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2017 | 1551 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2007 | 330 | 0.020 |
Why?
|
Imines | 1 | 2005 | 7 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2007 | 423 | 0.020 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 1 | 2005 | 26 | 0.020 |
Why?
|
Alcohol Dehydrogenase | 1 | 2005 | 30 | 0.020 |
Why?
|
Psychometrics | 1 | 1989 | 625 | 0.020 |
Why?
|
Cephalosporin Resistance | 1 | 2005 | 1 | 0.020 |
Why?
|
Cefotaxime | 1 | 2005 | 4 | 0.020 |
Why?
|
Ceftazidime | 1 | 2005 | 7 | 0.020 |
Why?
|
Rats | 2 | 2006 | 6688 | 0.020 |
Why?
|
PC12 Cells | 1 | 2005 | 50 | 0.020 |
Why?
|
Histidine | 1 | 2005 | 60 | 0.020 |
Why?
|
Isoproterenol | 1 | 2005 | 156 | 0.020 |
Why?
|
Laboratories | 1 | 2005 | 75 | 0.020 |
Why?
|
Adrenergic beta-Agonists | 1 | 2005 | 148 | 0.020 |
Why?
|
Pseudogenes | 1 | 2003 | 25 | 0.020 |
Why?
|
Genes, Protozoan | 1 | 2003 | 11 | 0.020 |
Why?
|
Aging | 1 | 2014 | 1613 | 0.020 |
Why?
|
Arginine | 1 | 2005 | 223 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2004 | 166 | 0.020 |
Why?
|
Bronchodilator Agents | 1 | 2005 | 217 | 0.020 |
Why?
|
CD3 Complex | 1 | 2003 | 93 | 0.020 |
Why?
|
Gene Duplication | 1 | 2003 | 81 | 0.020 |
Why?
|
Cause of Death | 1 | 2005 | 358 | 0.020 |
Why?
|
Kuwait | 1 | 2002 | 1 | 0.020 |
Why?
|
Israel | 1 | 2003 | 39 | 0.020 |
Why?
|
CD4 Antigens | 1 | 2003 | 134 | 0.020 |
Why?
|
Bromodeoxyuridine | 1 | 2002 | 86 | 0.020 |
Why?
|
Microbiological Techniques | 1 | 2003 | 40 | 0.020 |
Why?
|
Chemotaxis | 1 | 2003 | 115 | 0.020 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2003 | 48 | 0.020 |
Why?
|
Bipolar Disorder | 1 | 2005 | 205 | 0.020 |
Why?
|
beta-Galactosidase | 1 | 2002 | 108 | 0.020 |
Why?
|
Peptides | 1 | 2009 | 1012 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2005 | 334 | 0.020 |
Why?
|
Microelectrodes | 1 | 2001 | 38 | 0.020 |
Why?
|
Fires | 1 | 2002 | 70 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 2001 | 74 | 0.020 |
Why?
|
Lymphocyte Antigen 96 | 1 | 2001 | 32 | 0.020 |
Why?
|
CHO Cells | 1 | 2001 | 161 | 0.020 |
Why?
|
Nuclear Family | 1 | 2001 | 55 | 0.020 |
Why?
|
Respiratory Tract Infections | 1 | 2004 | 255 | 0.020 |
Why?
|
Clone Cells | 1 | 2001 | 241 | 0.020 |
Why?
|
Cricetinae | 1 | 2001 | 300 | 0.020 |
Why?
|
Histocompatibility Testing | 1 | 2001 | 130 | 0.010 |
Why?
|
Calcium | 1 | 2007 | 1267 | 0.010 |
Why?
|
Internet | 1 | 2005 | 584 | 0.010 |
Why?
|
Functional Laterality | 1 | 2001 | 269 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2001 | 620 | 0.010 |
Why?
|
Acoustic Stimulation | 1 | 2001 | 376 | 0.010 |
Why?
|
Reaction Time | 1 | 2001 | 479 | 0.010 |
Why?
|
Cell Membrane | 1 | 2003 | 777 | 0.010 |
Why?
|
Electroencephalography | 1 | 2001 | 464 | 0.010 |
Why?
|
Comorbidity | 1 | 2004 | 1472 | 0.010 |
Why?
|
Attention | 1 | 2001 | 450 | 0.010 |
Why?
|
Brain Mapping | 1 | 2001 | 568 | 0.010 |
Why?
|
Lung Volume Measurements | 1 | 1997 | 34 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2003 | 970 | 0.010 |
Why?
|
Organ Size | 1 | 1997 | 505 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2002 | 734 | 0.010 |
Why?
|
Proteus | 1 | 1993 | 6 | 0.010 |
Why?
|
Pseudomonas | 1 | 1993 | 24 | 0.010 |
Why?
|
Klebsiella pneumoniae | 1 | 1993 | 29 | 0.010 |
Why?
|
Colony Count, Microbial | 1 | 1993 | 95 | 0.010 |
Why?
|
Surveys and Questionnaires | 1 | 2004 | 3983 | 0.010 |
Why?
|
Administration, Oral | 1 | 1993 | 778 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 1993 | 944 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1993 | 1632 | 0.010 |
Why?
|